There are 2949 resources available
Q&A and live discussion
Presenter: Natasha Leighl
Session: Maximising the benefit of immuno-oncology
Resources:
Webcast
Q&A and live discussion
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Webcast
cfDNA in CNS tumours
Presenter: Joan Seoane
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
Cell-free DNA methylomes and early-stage cancers
Presenter: Daniel De Carvalho
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
High-sensitivity ctDNA assays to detect low-burden disease
Presenter: Nitzan Rosenfeld
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
The clinical perspective: Trials fit for purpose in 2020 and beyond
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The regulatory perspective: How to look for certainty in terra incognita
Presenter: Francesco Pignatti
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The HTA perspective: Is tissue-independent approval the next top model?
Presenter: Sonia Garcia Perez
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Implementation of NGS diagnostics in the NHS: The example of Belgium
Presenter: Marc Van Den Bulcke
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Evidence-based screening interventions: State-of-the-art
Presenter: Dario Trapani
Session: How can we reduce cancer numbers? (in collaboration with ASCO)
Resources:
Slides
Webcast